{"count": 18, "results": [{"_id": "34422646", "pmid": 34422646, "pmcid": "PMC8377676", "title": "The Effects of NT-1044, a Novel AMPK Activator, on Endometrial Cancer Cell Proliferation, Apoptosis, Cell Stress and In Vivo Tumor Growth", "journal": "Front Oncol", "authors": ["Roque DR", "Zhang L", "Wysham WZ", "Han J", "Sun W", "Yin Y", "Livingston JN", "Batchelor KW", "Zhou C", "Bae-Jump VL"], "date": "2021-08-05T00:00:00Z", "doi": "10.3389/fonc.2021.690435", "meta_date_publication": "2021", "meta_volume": "11", "meta_issue": "", "meta_pages": "690435", "score": 50268.53, "text_hl": "@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@Anti-diabetic biguanide@@@ drugs such as @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ may have anti-@<m>DISEASE_Cell_Transformation_Neoplastic</m> @DISEASE_MESH:D002471 @@@tumorigenic@@@ effects by behaving as @GENE_PRKAA2 @GENE_5563 @@@AMPK@@@ activators and @GENE_MTOR @GENE_2475 @@@mTOR@@@ inhibitors. ", "citations": {"NLM": "Roque DR, Zhang L, Wysham WZ, Han J, Sun W, Yin Y, Livingston JN, Batchelor KW, Zhou C, Bae-Jump VL. The Effects of NT-1044, a Novel AMPK Activator, on Endometrial Cancer Cell Proliferation, Apoptosis, Cell Stress and In Vivo Tumor Growth Front Oncol. 2021;11():690435. PMID: 34422646", "BibTeX": "@article{34422646, title={The Effects of NT-1044, a Novel AMPK Activator, on Endometrial Cancer Cell Proliferation, Apoptosis, Cell Stress and In Vivo Tumor Growth}, author={Roque DR and Zhang L and Wysham WZ and Han J and Sun W and Yin Y and Livingston JN and Batchelor KW and Zhou C and Bae-Jump VL}, journal={Front Oncol}, volume={11}, pages={690435}}"}}, {"_id": "39201569", "pmid": 39201569, "title": "Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?", "journal": "Int J Mol Sci", "authors": ["Papini N", "Giussani P", "Tringali C"], "date": "2024-08-15T00:00:00Z", "doi": "10.3390/ijms25168884", "meta_date_publication": "2024 Aug 15", "meta_volume": "25", "meta_issue": "16", "meta_pages": "", "score": 50261.59, "text_hl": "In addition to warranting good short- and long-term glycemic control, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ displays many intriguing properties as protection against @DISEASE_Neurodegenerative_Diseases @DISEASE_MESH:D019636 @@@cardiovascular and neurodegenerative diseases@@@, anti-@<m>DISEASE_Cell_Transformation_Neoplastic</m> @DISEASE_MESH:D002471 @@@tumorigenic@@@ and longevity promotion. ", "citations": {"NLM": "Papini N, Giussani P, Tringali C. Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases? Int J Mol Sci. 2024 Aug 15;25(16):. PMID: 39201569", "BibTeX": "@article{39201569, title={Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?}, author={Papini N and Giussani P and Tringali C}, journal={Int J Mol Sci}, volume={25}, number={16}}"}}, {"_id": "35525887", "pmid": 35525887, "title": "Synergy between sublethal doses of shikonin and metformin fully inhibits breast cancer cell migration and reverses epithelial-mesenchymal transition.", "journal": "Mol Biol Rep", "authors": ["Tabari AR", "Gavidel P", "Sabouni F", "Gardaneh M"], "date": "2022-06-01T00:00:00Z", "doi": "10.1007/s11033-022-07265-9", "meta_date_publication": "2022 Jun", "meta_volume": "49", "meta_issue": "6", "meta_pages": "4307-4319", "score": 50256.43, "text_hl": "CONCLUSIONS: @CHEMICAL_shikonin @CHEMICAL_MESH:C016101 @@@Shikonin@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ synergize in inhibiting the @<m>DISEASE_Cell_Transformation_Neoplastic</m> @DISEASE_MESH:D002471 @@@tumorigenic@@@ activities of @CELLLINE_CVCL:0031 @@@MCF-7@@@ cells including their proliferation, invasiveness, and EMT with a potential to inhibit multidrug resistance.", "citations": {"NLM": "Tabari AR, Gavidel P, Sabouni F, Gardaneh M. Synergy between sublethal doses of shikonin and metformin fully inhibits breast cancer cell migration and reverses epithelial-mesenchymal transition. Mol Biol Rep. 2022 Jun;49(6):4307-4319. PMID: 35525887", "BibTeX": "@article{35525887, title={Synergy between sublethal doses of shikonin and metformin fully inhibits breast cancer cell migration and reverses epithelial-mesenchymal transition.}, author={Tabari AR and Gavidel P and Sabouni F and Gardaneh M}, journal={Mol Biol Rep}, volume={49}, number={6}, pages={4307-4319}}"}}, {"_id": "37030634", "pmid": 37030634, "title": "Metformin inhibits neutrophil extracellular traps-promoted pancreatic carcinogenesis in obese mice.", "journal": "Cancer Lett", "authors": ["Wang G", "Gao H", "Dai S", "Li M", "Gao Y", "Yin L", "Zhang K", "Zhang J", "Jiang K", "Miao Y", "Lu Z"], "date": "2023-05-28T00:00:00Z", "doi": "10.1016/j.canlet.2023.216155", "meta_date_publication": "2023 May 28", "meta_volume": "562", "meta_issue": "", "meta_pages": "216155", "score": 50253.78, "text_hl": "The latter could induce an @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ response in ductal cells via @GENE_TLR4 @GENE_21898 @@@TLR4@@@-dependent pathways both in vivo and vitro, as demonstrated by upregulation of @GENE_IL1B @GENE_16176 @@@IL-1beta@@@. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and @GENE_DNASE1 @GENE_13419 @@@DNase I@@@ significantly reversed the pro-@<m>DISEASE_Cell_Transformation_Neoplastic</m> @DISEASE_MESH:D002471 @@@tumorigenic@@@ effects of @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obesity@@@ and @DISEASE_Periodic_fever_familial_autosomal_dominant @DISEASE_MESH:C536657 @@@NETs@@@ in vivo and in vitro. ", "citations": {"NLM": "Wang G, Gao H, Dai S, Li M, Gao Y, Yin L, Zhang K, Zhang J, Jiang K, Miao Y, Lu Z. Metformin inhibits neutrophil extracellular traps-promoted pancreatic carcinogenesis in obese mice. Cancer Lett. 2023 May 28;562():216155. PMID: 37030634", "BibTeX": "@article{37030634, title={Metformin inhibits neutrophil extracellular traps-promoted pancreatic carcinogenesis in obese mice.}, author={Wang G and Gao H and Dai S and Li M and Gao Y and Yin L and Zhang K and Zhang J and Jiang K and Miao Y and Lu Z}, journal={Cancer Lett}, volume={562}, pages={216155}}"}}, {"_id": "39379144", "pmid": 39379144, "title": "Metformin in Overcoming Enzalutamide Resistance in Castration-Resistant Prostate Cancer.", "journal": "J Pharmacol Exp Ther", "authors": ["Simpson K", "Allison DB", "He D", "Liu J", "Wang C", "Liu X"], "date": "2024-10-08T00:00:00Z", "doi": "10.1124/jpet.124.002424", "meta_date_publication": "2024 Oct 8", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50250.316, "text_hl": "This highlights the necessity for developing novel therapeutic targets to combat the gain of resistance. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ has been recently investigated for its potential anti-@<m>DISEASE_Cell_Transformation_Neoplastic</m> @DISEASE_MESH:D002471 @@@tumorigenic@@@ effects in many @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancer@@@ types. ", "citations": {"NLM": "Simpson K, Allison DB, He D, Liu J, Wang C, Liu X. Metformin in Overcoming Enzalutamide Resistance in Castration-Resistant Prostate Cancer. J Pharmacol Exp Ther. 2024 Oct 8;():. PMID: 39379144", "BibTeX": "@article{39379144, title={Metformin in Overcoming Enzalutamide Resistance in Castration-Resistant Prostate Cancer.}, author={Simpson K and Allison DB and He D and Liu J and Wang C and Liu X}, journal={J Pharmacol Exp Ther}}"}}, {"_id": "33946426", "pmid": 33946426, "pmcid": "PMC8147131", "title": "Metformin Dysregulates the Unfolded Protein Response and the WNT/beta-Catenin Pathway in Endometrial Cancer Cells through an AMPK-Independent Mechanism", "journal": "Cells", "authors": ["Conza D", "Mirra P", "Calì G", "Insabato L", "Fiory F", "Beguinot F", "Ulianich L"], "date": "2021-04-30T00:00:00Z", "doi": "10.3390/cells10051067", "meta_date_publication": "2021 Apr 30", "meta_volume": "10", "meta_issue": "5", "meta_pages": "", "score": 50247.484, "text_hl": "Multiple lines of evidence suggest that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, an antidiabetic drug, exerts anti-@<m>DISEASE_Cell_Transformation_Neoplastic</m> @DISEASE_MESH:D002471 @@@tumorigenic@@@ effects in different types of @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancer@@@. ", "citations": {"NLM": "Conza D, Mirra P, Calì G, Insabato L, Fiory F, Beguinot F, Ulianich L. Metformin Dysregulates the Unfolded Protein Response and the WNT/beta-Catenin Pathway in Endometrial Cancer Cells through an AMPK-Independent Mechanism Cells. 2021 Apr 30;10(5):. PMID: 33946426", "BibTeX": "@article{33946426, title={Metformin Dysregulates the Unfolded Protein Response and the WNT/beta-Catenin Pathway in Endometrial Cancer Cells through an AMPK-Independent Mechanism}, author={Conza D and Mirra P and Calì G and Insabato L and Fiory F and Beguinot F and Ulianich L}, journal={Cells}, volume={10}, number={5}}"}}, {"_id": "40024215", "pmid": 40024215, "title": "Modulation of M1 and M2 macrophage polarization by metformin: Implications for inflammatory diseases and malignant tumors.", "journal": "Int Immunopharmacol", "authors": ["Jafarzadeh S", "Nemati M", "Zandvakili R", "Jafarzadeh A"], "date": "2025-03-01T00:00:00Z", "doi": "10.1016/j.intimp.2025.114345", "meta_date_publication": "2025 Mar 1", "meta_volume": "151", "meta_issue": "", "meta_pages": "114345", "score": 50246.957, "text_hl": "In addition to antidiabetic impacts, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ also possesses multiple biological activities, including immunomodulatory, anti-@DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@, anti-@<m>DISEASE_Cell_Transformation_Neoplastic</m> @DISEASE_MESH:D002471 @@@tumorigenic@@@, anti-aging, cardioprotective, hepatoprotective, and tissue-regenerative properties. ", "citations": {"NLM": "Jafarzadeh S, Nemati M, Zandvakili R, Jafarzadeh A. Modulation of M1 and M2 macrophage polarization by metformin: Implications for inflammatory diseases and malignant tumors. Int Immunopharmacol. 2025 Mar 1;151():114345. PMID: 40024215", "BibTeX": "@article{40024215, title={Modulation of M1 and M2 macrophage polarization by metformin: Implications for inflammatory diseases and malignant tumors.}, author={Jafarzadeh S and Nemati M and Zandvakili R and Jafarzadeh A}, journal={Int Immunopharmacol}, volume={151}, pages={114345}}"}}, {"_id": "34664819", "pmid": 34664819, "title": "Modulatory Effects of Metformin Alone and in Combination with Cimetidine and Ibuprofen on T Cell-related Parameters in a Breast Cancer Model.", "journal": "Iran J Allergy Asthma Immunol", "authors": ["Taghipour F", "Oladpour O", "Rezayati MT", "Khorramdelazad H", "Nemati M", "Taghipour Z", "Masoumi J", "Hassan ZM", "Jafarzadeh A"], "date": "2021-09-28T00:00:00Z", "doi": "10.18502/ijaai.v20i5.7410", "meta_date_publication": "2021 Sep 28", "meta_volume": "20", "meta_issue": "5", "meta_pages": "600-613", "score": 50242.742, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@, @CHEMICAL_Cimetidine @CHEMICAL_MESH:D002927 @@@cimetidine@@@, and @CHEMICAL_Ibuprofen @CHEMICAL_MESH:D007052 @@@ibuprofen@@@ separately exhibit immunomodulatory and anti-@<m>DISEASE_Cell_Transformation_Neoplastic</m> @DISEASE_MESH:D002471 @@@tumorigenic@@@ effects. ", "citations": {"NLM": "Taghipour F, Oladpour O, Rezayati MT, Khorramdelazad H, Nemati M, Taghipour Z, Masoumi J, Hassan ZM, Jafarzadeh A. Modulatory Effects of Metformin Alone and in Combination with Cimetidine and Ibuprofen on T Cell-related Parameters in a Breast Cancer Model. Iran J Allergy Asthma Immunol. 2021 Sep 28;20(5):600-613. PMID: 34664819", "BibTeX": "@article{34664819, title={Modulatory Effects of Metformin Alone and in Combination with Cimetidine and Ibuprofen on T Cell-related Parameters in a Breast Cancer Model.}, author={Taghipour F and Oladpour O and Rezayati MT and Khorramdelazad H and Nemati M and Taghipour Z and Masoumi J and Hassan ZM and Jafarzadeh A}, journal={Iran J Allergy Asthma Immunol}, volume={20}, number={5}, pages={600-613}}"}}, {"_id": "37980327", "pmid": 37980327, "title": "A Mechanism of Action of Metformin in the Brain: Prevention of Methylglyoxal-Induced Glutamatergic Impairment in Acute Hippocampal Slices.", "journal": "Mol Neurobiol", "authors": ["Vizuete AFK", "Fróes F", "Seady M", "Hansen F", "Ligabue-Braun R", "Gonçalves CA", "Souza DO"], "date": "2023-11-18T00:00:00Z", "doi": "10.1007/s12035-023-03774-1", "meta_date_publication": "2023 Nov 18", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50242.527, "text_hl": "However, the precise mechanism of action of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in the central nervous system (CNS) needs to be clarified. ", "citations": {"NLM": "Vizuete AFK, Fróes F, Seady M, Hansen F, Ligabue-Braun R, Gonçalves CA, Souza DO. A Mechanism of Action of Metformin in the Brain: Prevention of Methylglyoxal-Induced Glutamatergic Impairment in Acute Hippocampal Slices. Mol Neurobiol. 2023 Nov 18;():. PMID: 37980327", "BibTeX": "@article{37980327, title={A Mechanism of Action of Metformin in the Brain: Prevention of Methylglyoxal-Induced Glutamatergic Impairment in Acute Hippocampal Slices.}, author={Vizuete AFK and Fróes F and Seady M and Hansen F and Ligabue-Braun R and Gonçalves CA and Souza DO}, journal={Mol Neurobiol}}"}}, {"_id": "29329345", "pmid": 29329345, "pmcid": "PMC5766148", "title": "Survival benefit associated with metformin use in inoperable non-small cell lung cancer patients with diabetes: A population-based retrospective cohort study", "journal": "PLoS One", "authors": ["Chuang MC", "Yang YH", "Tsai YH", "Hsieh MJ", "Lin YC", "Lin CK", "Chen PC", "Yang TM"], "date": "2018-01-12T00:00:00Z", "doi": "10.1371/journal.pone.0191129", "meta_date_publication": "2018", "meta_volume": "13", "meta_issue": "1", "meta_pages": "e0191129", "score": 50077.906, "text_hl": "However, future prospective randomized clinical trials are needed to validate the anti-@<m>DISEASE_Cell_Transformation_Neoplastic</m> @DISEASE_MESH:D002471 @@@tumorigenic@@@ activities of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@.", "citations": {"NLM": "Chuang MC, Yang YH, Tsai YH, Hsieh MJ, Lin YC, Lin CK, Chen PC, Yang TM. Survival benefit associated with metformin use in inoperable non-small cell lung cancer patients with diabetes: A population-based retrospective cohort study PLoS One. 2018;13(1):e0191129. PMID: 29329345", "BibTeX": "@article{29329345, title={Survival benefit associated with metformin use in inoperable non-small cell lung cancer patients with diabetes: A population-based retrospective cohort study}, author={Chuang MC and Yang YH and Tsai YH and Hsieh MJ and Lin YC and Lin CK and Chen PC and Yang TM}, journal={PLoS One}, volume={13}, number={1}, pages={e0191129}}"}}]}